Update of the management of postoperative endophthalmitis

Hong Kong Medical Journal

Volumn 10, Issue 5, 2004, Pages 337-343

  Yam, J C S ^a   Kwok, A K H ^a  

^a HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

Antibacterial agents; Blister; Endophthalmitis; Postoperative complications; Vitrectomy

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; CORTICOSTEROID; DEXAMETHASONE; GATIFLOXACIN; GENTAMICIN; HEPARIN; OFLOXACIN; POVIDONE IODINE; PREDNISOLONE ACETATE; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM CHLORIDE; VANCOMYCIN;

ACUTE DISEASE; ACUTE POSTOPERATIVE ENDOPHTHALMITIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BLEB ASSOCIATED ENDOPHTHALMITIS; CHRONIC DISEASE; CHRONIC POSTOPERATIVE ENDOPHTHALMITIS; CLINICAL FEATURE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG PENETRATION; DRUG TOLERABILITY; ENDOPHTHALMITIS; EYE DISEASE; EYE SURGERY; EYE TOXICITY; EYELASH; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION RISK; LAVAGE; MICROBIOLOGY; POSTOPERATIVE ENDOPHTHALMITIS; POSTOPERATIVE INFECTION; PROGNOSIS; RETINA BLOOD VESSEL OCCLUSION; RETINA DETACHMENT; REVIEW; RISK FACTOR; STEROID THERAPY; SYSTEMIC THERAPY; VISION; VITRECTOMY;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; ENDOPHTHALMITIS; HUMANS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS;

EID: 5644249574     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Eifrig CW, Flynn HW Jr, Scott IU, Newton J. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers 2002;33:373-8.
2. Speaker MG, Menikoff JA. Postoperative endophthalmitis: pathogenesis, prophylaxis, and management. Int Ophthalmol Clin 1993;33:51-70.
3. Chung CF, Lam DS. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol 2004;137:598-9.
4. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996;122:1-17.
5. Ciulla TA, Beck AD, Topping TM, Baker AS. Blebitis, early endophthalmitis, and late endophthalmitis after glaucoma-filtering surgery. Ophthalmology 1997;104:986-95.
6. Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology 2002;109:985-91.
7. Sharma S, Das D, Anand R, Das T, Kannabiran C. Reliability of nested polymerase chain reaction in the diagnosis of bacterial endophthalmitis. Am J Ophthalmol 2002;133:142-4.
8. Peyman GA, Bassili SS. A practical guideline for management of endophthalmitis. Ophthalmic Surg 1995;26:294-303.
9. Campochiaro PA, Conway BP. Aminoglycoside toxicity: a survey of retinal specialists. Implications for ocular use. Arch Ophthalmol 1991;109:946-50.
10. D'Amico DJ, Caspers-Velu L, Libert J, et al. Comparative toxicity of intravitreal aminoglycoside antibiotics. Am J Ophthalmol 1985;100:264-75.
11. Kwok AK, Hui M, Pang CP, et al. An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis. Invest Ophthalmol Vis Sci 2002;43:1182-8.
12. Doft BH, Barza M. Ceftazidime or amikacin: choice of intravitreal antimicrobials in the treatment of postoperative endophthalmitis. Arch Ophthalmol 1994;112:17-8.
13. Roth DB, Flynn HW Jr. Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy. Surv Ophthalmol 1997;41:395-401.
14. Shaarawy A, Grand MG, Meredith TA, Ibanez HE. Persistent endophthalmitis after intravitreal antimicrobial therapy. Ophthalmology 1995;102:382-7.
15. Oum BS, D'Amico DJ, Kwak HW, Wong KW. Intravitreal antibiotic therapy with vancomycin and aminoglycoside: examination of retinal toxicity of repetitive injections after vitreous and lens surgery. Graefes Arch Clin Exp Ophthalmol 1992;230:56-61.
16. Ferencz JR, Assia EI, Diamantstein L, Rubinstein E. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis. Arch Ophthalmol 1999;117:1023-7.
17. Souli M, Kopsinis G, Kavouklis E, Gabriel L, Giamarellou H. Vancomycin levels in human aqueous humour after intravenous and subconjunctival administration. Int J Antimicrob Agents 2001;18:239-43.
18. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133:463-6.
19. Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol 2003;121:345-50.
20. Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br J Ophthalmol 1999;83:1050-5.
21. Shah GK, Stein JD, Sharma S, et al. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 2000;107:486-9.
22. Majji AB, Jalali S, Das T, Gopinathan U. Role of intravitreal dexamethasone in exogenous fungal endophthalmitis. Eye 1999;13:660-5.
23. Bauman WC, D'Amico DJ. Surgical techniques in diagnosis and management of suspected endophthalmitis. Int Ophthalmol Clin 1992;32:113-28.
24. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-96.
25. Kwak HW, D'Amico DJ. Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. Arch Ophthalmol 1992;110:259-66.
26. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol 1998;43:193-224.
27. Aldave AJ, Stein JD, Deramo VA, Shah GK, Fischer DH, Maguire JI. Treatment strategies for postoperative Propionibacterium acnes endophthalmitis. Ophthalmology 1999;106:2395-401.
28. Clark WL, Kaiser PK, Flynn HW Jr, Belfort A, Miller D, Meisler DM. Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology 1999;106:1665-70.
29. Ciulla TA. Update on acute and chronic endophthalmitis. Ophthalmology 1999;106:2237-8.
30. Luttrull JK, Wan WL, Kubak BM, Smith MD, Oster HA. Treatment of ocular fungal infections with oral fluconazole. Am J Ophthalmol 1995;119:477-81.
31. Chen PP, Gedde SJ, Budenz DL, Parrish RK 2nd. Outpatient treatment of bleb infection. Arch Ophthalmol 1997;115:1124-8.
32. Sternberg P Jr, Martin DF. Management of endophthalmitis in the post-endophthalmitis vitrectomy study era. Arch Ophthalmol 2001;119:754-5.
33. Soltau JB, Rothman RF, Budenz DL, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol 2000;118:338-42.
34. Kangas TA, Greenfield DS, Flynn HW Jr, Parrish RK 2nd, Palmberg P. Delayed-onset endophthalmitis associated with conjunctival filtering blebs. Ophthalmology 1997;104:746-52.
35. Doft BH, Kelsey SF, Wisniewski SR. Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study. Ophthalmology 1998;105:707-16.
36. Doft BM, Kelsey SF, Wisniewski SR. Retinal detachment in the endophthalmitis vitrectomy study. Arch Ophthalmol 2000;118:1661-5.
37. Waheed S, Liebmann JM, Greenfield DS, et al. Recurrent bleb infections. Br J Ophthalmol 1998;82:926-9.
38. Akova YA, Bulut S, Dabil H, Duman S. Late bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmic Surg Lasers 1999;30:146-51.
39. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 2002;109:13-24.